wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q24633710-03BA344A-264E-4B5B-B47D-8D77A5DF4C29
Q24633710-03BA344A-264E-4B5B-B47D-8D77A5DF4C29
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24633710-03BA344A-264E-4B5B-B47D-8D77A5DF4C29
Update on the rational use of Y-ibritumomab tiuxetan in the treatment of follicular lymphoma
P2860
Q24633710-03BA344A-264E-4B5B-B47D-8D77A5DF4C29
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24633710-03BA344A-264E-4B5B-B47D-8D77A5DF4C29
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
114b32941c4e838a06e57ff04c844d39d96c4860
P2860
High activity 90Y-ibritumomab tiuxetan (Zevalin) with peripheral blood progenitor cells support in patients with refractory/resistant B-cell non-Hodgkin lymphomas.